Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 7, 2000, Pages 391-399

  Flasshove, M ^a   Bardenheuer, W ^a   Schneider, A ^a   Hirsch, G ^a   Bach, P ^a   Bury, C ^a   Moritz, T ^a   Seeber, S ^a   Opalka, B ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Gene therapy; Green fluorescent protein; Internal promoter; Retroviral vector

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RETROVIRUS; SPLEEN FOCUS FORMING VIRUS;

3T3 CELLS; ANIMALS; ANTIGENS, CD34; DOWN-REGULATION; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MICE; NEOPLASMS; PHOSPHOGLYCERATE KINASE; PROMOTER REGIONS (GENETICS); RETROVIRIDAE; SIMIAN VIRUS 40; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 0033937095     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008487     Document Type: Article

References (43)

1. Aran JM, Gottesman MM, Pastan I (1994) Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 91: 3176-3180
2. Aran JM, Gottesman MM, Pastan I (1998) Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein. Cancer Gene Ther 5: 195-206
3. Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W (1995) Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 69: 7541-7547
4. Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W (1996) Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection. J Hematother 5: 323-329
5. Bertolini F, Battagli M, Lanza A, Palermo B, Soligo D, Robustelli della Cuna G (1997) Transwell stroma culture in the presence of FLT-ligand and thrombopoietin allows ex vivo expansion and gene transfer in NOD/SCID mice repopulating CD34 + CD38-cells. Blood 90 (Suppl 1): 365a
6. Bierhuizen MFA, Westerman Y, Visser TP, Dimjati W, Wognum AW, Wagemaker G (1997) Enhanced green fluorescent protein as selectable marker of retroviral- mediated gene transfer in immature hematopoietic bone marrow cells. Blood 90: 3304-3315
7. + hematopoietic cells expressing the enhanced green fluorescent protein (EGFP). Leukemia 13: 605-613
8. - immunodeficient patients. Science 270: 470-475
9. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN (1993) Gene marking to determine whether autologous marrow infusion restores long-term haematopoiesis in cancer patients. Lancet 342: 1134-1137
10. Cao G, Kuriyama S, Gao J, Mitoro A, Cui L, Nagao S, Zhang X, Tsujinoue H, Pan X, Fukui H, Qi Z (1999) In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression. Int J Oncol 15: 107-112
11. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC (1994) Green fluorescent protein as a marker for gene expression. Science 263: 802-805
12. Cormack BP, Valdivia RH, Falkow S (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33-38
13. v mice. Cell 42: 71-79
14. + cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther 9: 2629-2640
15. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85: 566-574
16. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990) Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820-7825
17. Gansbacher B, Zier K, Cronin K, Hantzopoulos PA, Bouchard B, Houghton A, Gilboa E, Golde D (1992) Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood 80: 2817-2825
18. Grande A, Piovani B, Aiuti A, Ottolenghi S, Mavilio F, Ferrari G (1999) Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Blood 93: 3276-3285
19. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG (1998) High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58: 14-19
20. Hanazono Y, Yu JM, Dunbar CE, Emmons RVB (1997) Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum Gene Ther 8: 1313-1319
21. + hematopoietic cells. Hum Gene Ther 8: 2193-2206
22. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E (1989) Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 86: 3519-3523
23. Hennemann B, Conneally E, Pawliuk R, Leboulch P, Rose-John S, Reid D, Chuo JY, Humphries RK, Eaves CJ (1999) Optimization of retroviral-mediated gene transfer to human NOD/ SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Exp Hematol 27: 817-825
24. Hennik PB van, Verstegen MMA, Bierhuizen MFA, Limón A, Wognum AW, Cancelas JA, Barquinero J, Ploemacher RE, Wagemaker G (1998) Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood 92: 4013-4022
25. Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C (1998) Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum Gene Ther 9: 33-42
26. Joyner A, Keller G, Phillips RA, Bernstein A (1983) Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature 305: 556-558
27. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R (1995) Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1: 1017-1023
28. Kotani H, Newton III PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5: 19-28
29. Li MX, Hantzopoulos PA, Banerjee D, Zhao SC, Schweitzer BI, Gilboa E, Bertino JR (1992) Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Hum Gene Ther 3: 381-390
30. Limon A, Briones J, Puig T, Carmona M, Fornas O, Cancelas JA, Nadal M, García J, Rueda F, Barquinero J (1997) High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 90: 3316-3321
31. Malik P, Krall WJ, Yu XJ, Zhou C, Kohn DB (1995) Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters. Blood 86: 2993-3005
32. Moritz T, Keller DC, Williams DA (1993) Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178: 529-536
33. Moritz T, Mackay W, Glassner BJ, Williams DA, Samson L (1995) Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 55: 2608-2614
34. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA (1996) Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88: 855-862
35. Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ (1992) Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111: 229-233
36. Ramiro AR, De Yébenes VG, Trigueros C, Carrasco YR, Toribio ML (1998) Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursors. Hum Gene Ther 9: 1103-1109
37. Ritchie KA, Aprikian A, Gollahon KA, Hickstein DD (1995) The human leukocyte integrin CD11a promoter directs expression in leukocytes of transgenic mice. Blood 86: 147-155
38. +-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther 8: 1611-1623
39. Skotzko M, Wu L, Anderson WF, Gordon EM, Hall FL (1995) Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res 55: 5493-5498
40. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257: 99-103
41. Sugimoto Y, Sato S, Tsukahara S, Suzuki M, Okochi E, Gottesman MM, Pastan I, Tsuruo T (1997) Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector HaMDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice. Cancer Gene Ther 4: 51-58
42. ++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 91: 431-440
43. Yang TT, Cheng L, Kain SR (1996) Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res 24: 4592-4593